Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1562-1565

  Chien, S C ^a   Chow, A T ^a   Natarajan, J ^a   Williams, R R ^a   Wong, F A ^a   Rogge, M C ^a   Nayak, R K ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

ADULT; AGE; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; KIDNEY FUNCTION; LEAN BODY WEIGHT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0030790098     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1562     Document Type: Article

References (15)

1. Bertino, J. S., Jr., and A. N. Nafziger. 1996. Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers. Antimicrob. Agents Chemother. 40:789-791.
2. Cockcroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31.
3. Epstein, M. 1979. Effect of aging on the kidney. Fed. Proc. 38:168-172.
4. Graber, H., E. Ludwig, M. Arr, and P. Lanyl. 1988. Pharmacokinetics of ofloxacin in young and elderly patients. Rev. Infect. Dis. 10(Suppl. 1):S106.
5. Greenblatt, D. J., E. M. Sellers, and R. I. Shader. 1982. Drug therapy: drug disposition in old age. N. Engl. J. Med. 306:1081-1088.
6. Molinaro, M., P. Villani, M. B. Regazzi, R. Rondanelli, and G. Doveri. 1992. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects. Eur. J. Clin. Pharmacol. 43:105-107.
7. Okazaki, O., C. Kojima, H. Hakusui, and M. Nakashima. 1991. Enantios-elective disposition of ofloxacin in humans. Antimicrob. Agents Chemother. 35:2106-2109.
8. Rogge, M. C., S.-C. Chien, and M. L. Holland. 1994. Single-dose pharmacokinetics of levofloxacin: influence of age and gender, abstr. A41, p. 18. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Rossman, I. 1979. Clinical geriatrics, p. 23-53, 132, 173, and 224-229. J. B. Lippincott, Philadelphia, Pa.
10. Rowland, M., and T. N. Tozer. 1980. Clinical pharmacokinetics: concepts and applications. Lea & Febiger, Philadelphia, Pa.
11. R. W. Johnson Pharmaceutical Research Institute. Unpublished data.
12. SAS Institute, Inc. 1990. SAS/STAT user's guide, version 6, 4th ed. SAS Institute, Inc., Cary, N.C.
13. Shah, A., J. Lettieri, D. Nix, J. Wilton, and A. H. Heller. 1995. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects. Antimicrob. Agents Chemother. 39:1003-1006.
14. Sorgel, F., K. Naber, G. Mahr, B. Gottschalk, U. Stephan, R. Seelmann, R. Metz, P. Muth, U. Jaehde, and J. Zurcher. 1991. Gender related distribution of quinolones. Eur. J. Clin. Microbiol. Infect. Dis. Special issue: 189-190.
15. Yuen, G. J. 1990. Altered pharmacokinetics in the elderly. Clin. Geriatr. Med. 6:257-267.